159730-72-0

Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-4-methyl-5-nitrobenzaldehyde is used as a building block for the synthesis of various pharmaceuticals. Its unique structure allows it to be incorporated into the development of new drugs, potentially enhancing their therapeutic effects and targeting specific diseases.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Bromo-4-methyl-5-nitrobenzaldehyde is utilized as a key component in the creation of pesticides and other agrochemicals. Its incorporation can lead to the development of more effective and targeted products for agricultural use.
Used in Dye Industry:
2-Bromo-4-methyl-5-nitrobenzaldehyde is also employed in the dye industry, where it serves as a crucial intermediate in the production of various dyes. Its chemical properties contribute to the colorfastness and stability of the dyes produced.
Used in Organic Reactions:
2-Bromo-4-methyl-5-nitrobenzaldehyde is used as a reagent in organic reactions to introduce its specific moiety into organic molecules. This can lead to the formation of new compounds with unique properties and potential applications.
Used in Drug Development:
Due to its anti-inflammatory and antimicrobial properties, 2-Bromo-4-methyl-5-nitrobenzaldehyde is studied as a potential candidate for drug development. Its ability to combat inflammation and inhibit microbial growth could lead to the creation of new therapeutic agents.
However, it is crucial to handle 2-Bromo-4-methyl-5-nitrobenzaldehyde with care, as it may pose health risks if not used properly. Proper safety measures and precautions should be taken during its synthesis, storage, and application to ensure the well-being of individuals involved in its use.

InChI:InChI=1/C8H6BrNO3/c1-5-2-7(9)6(4-11)3-8(5)10(12)13/h2-4H,1H3

Upstream product

• 824-54-4 2-bromo-4-methylbenzaldehyde 

Downstream Products

• 159730-73-1 ethyl 6-methyl-5-nitrobenzo[b]thiophene-2-carboxylate 
• 1029557-20-7 1-bromo-2-(difluoromethyl)-5-methyl-4-nitrobenzene 
• 184161-95-3 6-methyl-5-nitrobenzo[d]thiophen-2-carboxylic acid 
• 1029557-22-9 {3-[2-(difluoromethyl)-5-methyl-4-nitrophenoxy]propyl}(trimethyl)silane 
• 1029557-24-1 5-(difluoromethyl)-2-methyl-4-[3-(trimethylsilyl)propoxy]aniline 

Relevant academic research and scientific papers

Phenyl substituted fused tricyclic compound and uses thereof

The present invention relates to a phenyl substituted fused tricyclic compound and uses thereof, further to a pharmaceutical composition containing the compound. According to the present invention, the compound or the pharmaceutical composition can be use

Sequential Assembly of Morita-Baylis-Hillman Carbonates and Activated ortho-Vinylbenzaldehydes to Construct Chiral Methanobenzo[7]annulenone Frameworks

The α-regioselective asymmetric [3 + 2] annulation reaction of Morita-Baylis-Hillman carbonates from isatins and activated ortho-vinylbenzaldehyses was developed by the catalysis of a chiral tertiary amine. The sequential N-heterocyclic carbene-mediated intramolecular Stetter reaction was conducted to finally furnish the bridged 5,8-methanobenzo[7]annulen-9-one architectures incorporating a spirooxindole motif with excellent stereoselectivity.

Fluoralkylphenylamidines and the use thereof as fungicides

The present invention relates to fluoroalkylphenylamidines of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and also to a composition for this pur

FUNGICIDAL MIXTURES OF AMIDINYLPHENYL COMPOUNDS

This invention relates to fungicidal mixtures of certain phenylamidines, their N-oxides, and/or agriculturally suitable salts thereof, and to compositions comprising such mixtures and methods for using such mixtures as fungicides.

Synthesis, biological activity, and molecular modeling studies of selective 5-HT(2C/2B) receptor antagonists

The synthesis and biological activity are reported for a series of analogues of the previously published indole urea 2 (SB-206553), designed to probe the 5-HT(2C) receptor binding site. Small molecule modeling studies have been used to define a region in space which is allowed at the 5-HT(2C) receptor but disallowed at the 5-HT(2A) receptor. In a complementary approach, docking of 2 into our model of the 5-HT(2C) receptor has allowed us to propose a novel primary binding interaction for this series of diaryl ureas, involving a potential double hydrogen-bonding interaction between the urea carbonyl oxygen of the ligand and two serine residues in the receptor. The difference of two valine residues in the 5-HT(2C) receptor for leucine residues in the 5-HT(2A) receptor is believed to account for the observed 5- HT(2C)/5-HT(2A) selectivity with 2.